Australia Montelukast 4 mg
INDICATIONS & USAGE: seasonal allergic rhinitis...allergic rhinitis...Prophylaxis and chronic treatment of asthma in patients 2 years of age and older...eukotriene receptor antagonist...Serious neuropsychiatric (NP) events have been reported with the use of montelukast sodium....
oval white MS1 M
Related Pills
montelukast sodium tablet chewable
Camber Pharmaceuticals, Inc.
montelukast sodium tablet film coated montelukast sodium tablet chewable
Unichem Pharmaceuticals (USA), Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
Comments
9 months ago - Tuesday, Jan 23, 2024, 12:38 pm
Australia Montelukast 4 mg [oval white MS1 M] https://www.medsafe.govt.nz/consumers/cmi/m/MontelukastMylan.pdf